Evidence map›Paper›PMID 42508067›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Distinct Transcriptomic Profiles in ART-Treated People With HIV Are Associated With NF-κB-Regulated Gene Expression and Inflammatory Cytokine Signatures.

Yingfan Wang, German G Gornalusse, Urja Bhatt, David A Siegel, Alton Barbehenn, Rebecca Hoh, Jeffrey Martin, Frederick Hecht, Christopher Pilcher, Lesia Semenova and 9 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yingfan WangDepartment of Computer Science, Duke University, Durham, NC.
German G GornalusseDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Urja BhattDepartment of Genetics, UNC Chapel Hill, Chapel Hill, NC.
David A SiegelDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Alton BarbehennDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Rebecca HohDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Jeffrey MartinDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Frederick HechtDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Christopher PilcherDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Lesia SemenovaMicrosoft Research, New York, NY.
David M MurdochDepartment of Medicine, Duke University, Durham, NC.
David M MargolisDepartment of Medicine, UNC Chapel Hill, Chapel Hill, NC.
Claire N LevyDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA.
Keith R JeromeDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
Cynthia D RudinDepartment of Computer Science, Duke University, Durham, NC.
Florian HladikVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.
Steven G DeeksDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Sulggi A LeeDepartment of Medicine, Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, CA.
Edward P BrowneDepartment of Medicine, UNC Chapel Hill, Chapel Hill, NC.ORCID 0000-0001-9070-7015

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart · 1988 to 2026
$104.9M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI164567 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2021 to 2026
$31.6M
Cell and Gene Therapy for HIV CureUM1AI126623 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI JEROME, KEITH R, KIEM, HANS-PETER · 2016 to 2020
$24.2M
NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Role of intestinal microfold (M) cells in creating a hotspot environment for HIV reservoir persistence and reactivationR01AI184122 · NIAID · UNIVERSITY OF WASHINGTON · PI German Gustavo Gornalusse · 2024 to 2026
$2.5M
A machine learning framework for understanding impacts on the HIV latent reservoir size, including drugs of abuseR01DA054994 · NIDA · DUKE UNIVERSITY · PI RUDIN, CYNTHIA · 2021 to 2025
$2.3M
Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysisR61DA053599 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BROWNE, EDWARD P · 2021 to 2023
$2.0M
Regulation of HIV Latency by Host Cell Transcriptional and Epigenetic NetworksR01AI143381 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BROWNE, EDWARD P · 2019 to 2022
$1.6M
A pharmacogenomics study of HIV latency: the role of PD-1 signalingK23GM112526 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, SULGGI ANGELA · 2014 to 2018
$908k
ACCOMPLISH (Applied Coaching of COMPutational Learners In Substance use and HIV) Mentoring ProgramK24DA064477 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sulggi Angela Lee · 2025 to 2026
$412k
Bill & Melinda Gates Foundation INV-008500NCATS NIH HHS KL2 TR002317NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI143381NIAID NIH HHS R01 AI184122NIAID NIH HHS UM1 AI126623NIAID NIH HHS UM1 AI164567NIDA NIH HHS K24 DA064477NIDA NIH HHS R01 DA054994NIDA NIH HHS R61 DA053599NIGMS NIH HHS K23 GM112526NIH HHS K23GM112526NIH HHS KL2TR002317NIH HHS P30AI027757NIH HHS R01A141003NIH HHS R01AI143381NIH HHS R01AI184122NIH HHS R01DA054994NIH HHS UM1AI126623NIH HHS UM1AI164567
6 · The paper itself

Abstract

objectiveDespite effective antiretroviral therapy (ART), people with HIV (PWH) continue to experience elevated morbidity, potentially driven by persistent immune dysregulation. This study aimed to define transcriptomic heterogeneity in peripheral CD4 + T cells and identify immune signatures associated with clinical stratification in ART-treated PWH.

designWe analyzed transcriptomic and immunologic (plasma cytokine) data from a well-characterized cohort of ART-suppressed PWH to identify biologically meaningful subgroups.

methodsBulk RNA sequencing was performed on peripheral CD4 + T cells from 154 ART-treated PWH. Plasma levels of immune mediators were also quantified. We applied Pairwise Controlled Manifold Approximation (PaCMAP), a novel dimensionality reduction technique, to identify transcriptomic clusters and assessed their associations with clinical and immunological parameters, including CD4:CD8 ratio and cell-associated HIV DNA/RNA.

resultsPaCMAP identified 3 distinct transcriptomic clusters among PWH. These clusters were enriched for differential expression of genes regulated by NF-κB, suggesting a role for chronic immune activation and inflammation. While clustering was not associated with HIV reservoir size, there was a modest association with CD4:CD8 ratio, a key marker of immune recovery. In addition, plasma levels of IL-1β, TNF-α, and G-CSF differed across clusters, supporting a link between plasma cytokines and CD4 + T-cell transcriptomic diversity.

conclusionsOur findings define transcriptomic subgroups in ART-treated PWH that are characterized by NF-κB-driven gene expression and distinct inflammatory cytokine profiles. These immune signatures may serve as biomarkers for immunological stratification and provide insights into persistent immune dysfunction despite viral suppression.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsCytokinesHIV InfectionsNF-kappa BTranscriptomeAdultCD4-CD8 RatioCD4-Positive T-LymphocytesFemaleGene Expression ProfilingGene Expression RegulationHumansMaleMiddle AgedAnti-HIV AgentsAnti-Retroviral AgentsCytokinesNF-kappa BbiomarkersHIV infectionsphenotypeRNA-seqtranscriptome

Identifiers

PMID42508067
PMCPMC13686628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.